Twin Disc targets USD 500 million revenue by 2030, investor deck shows
Reuters2026/08/26 22:12- Twin Disc outlined FY26 sales of USD 381.3 million, up 11.9% year over year, with EBITDA of USD 29.9 million, up 48%.
- Net income totaled USD 27.1 million. Free cash flow was USD 9.2 million.
- Six-month backlog stood at USD 178.3 million as of 6/30/26, flat despite higher shipments and efforts to reduce past-due orders.
- Defense was about 17% of total backlog. Defense backlog rose 56% year over year. Identified defense pipeline was USD 30 million-50 million.
- Long-term targets call for USD 500 million revenue, 30% gross margin, more than 60% free-cash-flow conversion by fiscal 2030.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Most panda coin types from the 2026 edition steadily rebounded in August
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
